Close



Apr 1, 2024 06:40AM
Mar 31, 2024 07:30PM
Mar 11, 2024 02:01PM
Mar 8, 2024 10:15AM
Mar 8, 2024 10:04AM
Mar 8, 2024 06:51AM
Feb 23, 2024 07:01AM Biogen (BIIB) Reports Positive CHMP Opinion for QALSODY
Feb 23, 2024 07:00AM
Feb 12, 2024 04:06PM
Feb 12, 2024 04:06PM
Jan 31, 2024 07:55AM
Jan 31, 2024 07:30AM
Jan 31, 2024 07:30AM
Jan 31, 2024 07:30AM Biogen to Realign Resources for Alzheimer's Disease Franchise
Jan 30, 2024 08:30AM
Jan 3, 2024 08:00AM
Dec 15, 2023 09:06AM
Dec 15, 2023 09:05AM
Dec 14, 2023 06:31AM
Dec 14, 2023 06:30AM
Oct 25, 2023 05:35PM Eisai, Biogen (BIIB) Injectable-At-Home Alzheimer's Drug Demonstrates Encouraging Potential
Oct 25, 2023 05:25PM
Oct 24, 2023 09:30AM
Oct 19, 2023 07:30AM
Sep 29, 2023 04:06PM
Sep 29, 2023 04:06PM
Sep 26, 2023 09:09AM
Sep 26, 2023 08:59AM Biogen Completes Acquisition of Reata Pharmaceuticals
Sep 21, 2023 10:08AM
Aug 7, 2023 07:13AM
Aug 7, 2023 07:04AM
Aug 7, 2023 06:47AM
Aug 7, 2023 06:24AM
Aug 4, 2023 10:42PM
Aug 4, 2023 10:41PM FDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral Treatment Approved for Women with Postpartum Depression, and Issues a Complete Response Letter for Major Depressive Disorder
Jul 28, 2023 07:41AM
Jul 28, 2023 07:07AM
Jul 28, 2023 07:05AM
Jul 25, 2023 07:04AM
Jul 19, 2023 07:30PM
Jul 7, 2023 07:48AM
Jul 7, 2023 06:52AM Biogen (BIIB) will resume trading at 7:10 AM ET following FDA traditional approval of LEQEMBI
Jul 7, 2023 05:33AM
Jul 6, 2023 08:00PM
Jul 6, 2023 04:47PM
Jun 30, 2023 04:09PM
Jun 30, 2023 04:06PM
Jun 27, 2023 07:00AM
Jun 12, 2023 07:06AM Biogen shares jump after FDA advisory panel backs Alzheimer's drug
Jun 12, 2023 06:26AM

251,776 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All